Literature DB >> 2176213

Strong and persistent activation of inositol lipid breakdown induces early mitogenic events but not Go to S phase progression in hamster fibroblasts. Comparison of thrombin and carbachol action in cells expressing M1 muscarinic acetylcholine receptors.

K Seuwen1, C Kahan, T Hartmann, J Pouyssegur.   

Abstract

In order to evaluate the role of phosphoinositide turnover in growth factor action, we expressed human M1 muscarinic acetylcholine (Hm1) receptors in Chinese hamster lung fibroblasts (CCL39 cell line). In the transfected cells (39M1-81 clone), but not in wild type fibroblasts, the muscarinic agonist carbachol induced a release of inositol phosphates as strong as alpha-thrombin, a very potent growth factor and activator of phosphoinositide-specific phospholipase C (PLC) in this cell system. In contrast to thrombin, carbachol-stimulated PLC activity was not inhibited by pertussis toxin treatment of cells. At concentrations that elicited a comparable initial rate of inositol phosphate release (10 nM for thrombin and 0.1 mM for carbachol), both agents gave rise to an identical calcium signal and equally stimulated Na+/H+ exchange and the transcription of the early genes c-jun, c-fos, and c-myc. Surprisingly, however, carbachol is not a mitogen for 39M1-81 cells, and even if tested in association with insulin or fibroblast growth factor, its effects on cell proliferation remained weak when compared with thrombin. Also, the muscarinic agonist did not stimulate soft agar colony forming capacity and did not prevent growth arrest in Go upon serum deprivation of cycling 39M1-81 cells. The failure of carbachol to induce cell proliferation could not be attributed to rapid and complete desensitization of Hm1 receptors nor to the activation of inhibitory pathways like adenylyl cyclase stimulation. We conclude that strong and persistent activation of phosphoinositide turnover elicits early biochemical events generally associated with mitogenesis, but is not sufficient to stimulate or maintain continuous cell proliferation. On the basis of our results, we postulate that thrombin mitogenesis depends critically on signaling events different from phosphoinositide turnover, possibly the stimulation of a receptor tyrosine kinase or a Gi protein-activated tyrosine kinase.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2176213

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Thrombin inhibits Bim (Bcl-2-interacting mediator of cell death) expression and prevents serum-withdrawal-induced apoptosis via protease-activated receptor 1.

Authors:  Claire J Chalmers; Kathryn Balmanno; Kathryn Hadfield; Rebecca Ley; Simon J Cook
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

2.  Calcium activates Nedd4 E3 ubiquitin ligases by releasing the C2 domain-mediated auto-inhibition.

Authors:  Jian Wang; Qisheng Peng; Qiong Lin; Chandra Childress; David Carey; Wannian Yang
Journal:  J Biol Chem       Date:  2010-02-19       Impact factor: 5.157

3.  Coupling of the thrombin receptor to G12 may account for selective effects of thrombin on gene expression and DNA synthesis in 1321N1 astrocytoma cells.

Authors:  G R Post; L R Collins; E D Kennedy; S A Moskowitz; A M Aragay; D Goldstein; J H Brown
Journal:  Mol Biol Cell       Date:  1996-11       Impact factor: 4.138

4.  Analysis of the fibroblast transformation potential of GTPase-deficient gip2 oncogenes.

Authors:  S K Gupta; C Gallego; J M Lowndes; C M Pleiman; C Sable; B J Eisfelder; G L Johnson
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

5.  Shc adaptor proteins are key transducers of mitogenic signaling mediated by the G protein-coupled thrombin receptor.

Authors:  Y Chen; D Grall; A E Salcini; P G Pelicci; J Pouysségur; E Van Obberghen-Schilling
Journal:  EMBO J       Date:  1996-03-01       Impact factor: 11.598

6.  Differential activation of p44mapk (ERK1) by alpha-thrombin and thrombin-receptor peptide agonist.

Authors:  V Vouret-Craviari; E Van Obberghen-Schilling; J C Scimeca; E Van Obberghen; J Pouysségur
Journal:  Biochem J       Date:  1993-01-01       Impact factor: 3.857

7.  Differences in the regulation of endothelin-1- and lysophosphatidic-acid-stimulated Ins(1,4,5)P3 formation in rat-1 fibroblasts.

Authors:  R Plevin; E E MacNulty; S Palmer; M J Wakelam
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

8.  Thrombin receptor and RhoA mediate cell proliferation through integrins and cysteine-rich protein 61.

Authors:  Colin T Walsh; Julie Radeff-Huang; Rosalia Matteo; Albert Hsiao; Shankar Subramaniam; Dwayne Stupack; Joan Heller Brown
Journal:  FASEB J       Date:  2008-08-07       Impact factor: 5.191

9.  FMLP activates Ras and Raf in human neutrophils. Potential role in activation of MAP kinase.

Authors:  G S Worthen; N Avdi; A M Buhl; N Suzuki; G L Johnson
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

10.  Thrombin induces Egr-1 expression in fibroblasts involving elevation of the intracellular Ca2+ concentration, phosphorylation of ERK and activation of ternary complex factor.

Authors:  Oliver G Rössler; Gerald Thiel
Journal:  BMC Mol Biol       Date:  2009-05-11       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.